
|Articles|July 1, 2000
The American Journal of Managed Care
- July 2000
- Volume 6
- Issue 7
Clinical and Cost Implications of New Technologies for Cervical Cancer Screening: The Impact of Test Sensitivity
Advertisement
Articles in this issue
almost 26 years ago
Improving the Sensitivity of Cervical Cytology: What Are the Issues?almost 26 years ago
Why Are Drug Prices Lower in Canada?almost 26 years ago
Design and Implementation of an Inpatient Disease Management Programalmost 26 years ago
Managing Drug Costs: The Perception of Managed Care Pharmacy DirectorsAdvertisement
Advertisement
Advertisement
Trending on AJMC
1
Incretin Innovation, Metabolic Liver Disease, and Cardiovascular Risk Reduction Dominate ADA 2026
2
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
3
Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma
4
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
5




